FLOX in Combination With Cetuximab in First-line Treatment of Colorectal Cancer

Clinical trial NCT00145314 · COMPLETED

Trial details

NCT number: NCT00145314
Sponsor: The Nordic Colorectal Cancer Biomodulation Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2005-05-01
Primary completion: 2009-05-01
Enrollment: 571

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.